Assessment of the efficiency of the local application of hemostatic drug Geprocel in the treatment of patients with deep burns
DOI:
https://doi.org/10.5281/zenodo.2558592Keywords:
Burn trauma, Haemostatic medications, Geprocel, Intravascular coagulation syndrome, Surgical treatments.Abstract
The work is based on the analysis of the treatment results of 35 patients with burn trauma (10 women and 25 men) aged 15 to 55 years who were treated in the burn department of Republican Scientific Centre of Urgent Medical Aid (RSCUMA) between 2017 and 2018. In this study, we report on the use of the hemostatic preparation Geprocel with an autodermoplasty on a wound after necroectomy with subsequent autodermoplasty in all cases contributed to the complete healing of donor sites for 7 days, and the complete engraftment of the skin autotransplant with full recovery of the defect by 12 days after surgery. This preliminary data suggests the potential role of Geprocel in the clinical management of burn treatment.The work is based on the analysis of the treatment results of 35 patients with burn trauma (10 women and 25 men) aged 15 to 55 years who were treated in the burn department of Republican Scientific Centre of Urgent Medical Aid (RSCUMA) between 2017 and 2018. In this study, we report on the use of the hemostatic preparation Geprocel with an autodermoplasty on a wound after necroectomy with subsequent autodermoplasty in all cases contributed to the complete healing of donor sites for 7 days, and the complete engraftment of the skin autotransplant with full recovery of the defect by 12 days after surgery. This preliminary data suggests the potential role of Geprocel in the clinical management of burn treatment.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
The authors agreed following terms while submitting the article:
- Coauthors and I retain copyright and grant the journal right of first publication with the work and also agree that, if accepted by the editorial team, shall be licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (Articles can be shared and adapted, provided the attribution for the work is given and that the work is not used for commercial purposes), full details of which can be found here.
- I, on behalf of myself and my co-authors, authorize that:
- the article is original and was not published in any other peer-reviewed journal, and is not under consideration by any other journal, and does not violate any existing copyright or any other third party rights.